Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.25
Delayed Data
As of May 31
 +0.0357 / +2.95%
Today’s Change
0.58
Today|||52-Week Range
2.13
+29.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues669.3K0.0023.7K47.7K
 
 
 
 
Cost of Goods Sold--0.007.5K6.3K
 
 
 
Depreciation And Amortization20.5K17.4K48.2K68.4K
 
 
 
 
 
 
Operating ExpensesGross Income---17.4K-31.9K-26.9K
 
 
 
 
General Expenses5.2M5.7M6.5M7.1M
 
 
 
 
 
Research And Development2.4M2.7M2.8M4.1M
 
 
 
 
 
Total Operating Expenses5.2M5.7M6.5M7.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M-5.7M-6.5M-7.2M
 
 
 
 
 
Extraordinary Credit0.000.0011.8K27.5K
 
 
 
Extraordinary Charge0.000.00-19.7M0.00
 
 
Interest Expense On Debt10.0M0.0028.1K82.5K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.5M-5.7M-26.2M-7.2M
 
 
 
 
 
Preferred Dividend-335.0K0.000.000.00
 
 
Net Income-14.5M-5.7M-26.2M-7.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.1M26.1M28.6M32.4M
 
 
 
 
 
Shares To Calculate EPS Diluted19.1M26.1M28.6M32.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.78-$0.22-$0.92-$0.22
 
 
 
 
 
EPS Diluted-$0.78-$0.22-$0.92-$0.22